Tasnim S Waheeb
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 02, 2026
Repurposing of doxycycline as a novel therapeutic avenue for management of parkinson's disease.Naif H Ali, Hayder M Al-Kuraishy, Nawar R Hussain
|Mar 13, 2026
Cross-talk between pyroptosis and miRNAs in Alzheimer disease neuropathology, therapeutic targeting of NLRP inflammasomes, and recent advances in nanoparticle-targeted therapy.Hebatallah M Saad, Esraa Atef, Asmaa A Aboushouk
|Mar 03, 2026
Colchicine in COVID-19: Mechanistic Insights and Clinical Uncertainties.Abrar S Alsulami, Hayder M Al-Kuraishy, Tasnim S Waheeb
|Jan 19, 2026
Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key Player.Mansour Alanazi, Hayder M Al-Kuraishy, Nawar R Hussain
|Oct 15, 2025
Crosstalk between ferroptosis and miRNA in type 2 diabetes mellitus and possible therapeutic targeting.Hebatallah M Saad, Esraa A Salem, Omnya Elhussieny
|Mar 09, 2025
Neuroprotective efficacy of berberine and caffeine against rotenone-induced neuroinflammatory and oxidative disturbances associated with Parkinson's disease via inhibiting α-synuclein aggregation and boosting dopamine release.Tasnim S Waheeb, Mohammad A Abdulkader, Doaa A Ghareeb
Pageof 1
